via Chris MacDonald's Biotech Ethics Blog.
I'm less convinced than MacDonald that harm is only relevant moral standard in a case like this. Though, on the other hand, I'm more impressed than MacDonald with the prospects for this sort of testing leading benefits, both scientific and, as the proponents of the Berkeley plan had hoped, educational.
But even more so I reckon there's at least a few lawyers in Berkeley's risk management office who are breathing a sigh of relief: The state, specifically the California Department of Public Health, has taken a potential hot potato out of their hands.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment